The global contraceptives industry was valued at USD 31.1 billion in 2024 and is projected to reach USD 52.2 billion by the end of 2035, expanding at a CAGR of 5.3% from 2025 to 2035. Market growth is driven by rising awareness about family planning, increasing government initiatives for reproductive health, and growing demand for modern contraceptive methods worldwide.

👉 Get sample market research report copy today @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=344

Market Overview

Increasing acknowledgment of family planning and reproductive health will certainly be a major contributor to the global contraceptives market. As public health authorities, NGOs, and governments up the ante on awareness and education about reproductive rights, safe sex, and the health and economic benefits of Planned Parenthood, more people – especially in developing parts of the world – are looking to contraceptives as a choice in health.

Analysts’ Viewpoint on the Contraceptives Market

The global contraceptives market is an important aspect of the healthcare system as it aims to prevent unintended pregnancies and alleviate the burden of sexually transmitted diseases (STDs). The key driver is the rise in awareness of family planning, government initiatives, technological improvements in contraceptive methods, and preferences along the continuum of sexual health. More specifically, there is an overall need to respond to unintended pregnancies, increasing demand for reproductive health solutions (RHS), and increasingly appealing innovations such as long-acting reversible contraceptives (LARCs).

Analysis of Key Players

The competitive landscape is dominated by five major players who collectively hold over 42% of the market, though specialized biotech firms are gaining ground in non-hormonal R&D.

Leading companies operating in the global market include:

• Bayer AG (Market leader with ~14.2% share; dominant in hormonal IUDs like Mirena)
• Organon & Co. (Leader in long-acting implants with Nexplanon)
• Pfizer Inc. (Major player in injectable contraceptives like Depo-Provera)
• CooperSurgical, Inc. (Leading provider of copper IUDs)
• Reckitt Benckiser Group (Global leader in the condom segment via Durex)
• Teva Pharmaceutical Industries (Dominant in generic oral contraceptives)
• Perrigo Company plc (Pioneer in the OTC oral pill market with Opill)
• HRA Pharma (Now part of Perrigo; focused on emergency contraception)
• Agile Therapeutics (Specialists in transdermal contraceptive patches)
• Mylan N.V. (Viatris)

Recent Developments

• In February 2025, Sebela Women’s Health Inc., a part of Sebela Pharmaceuticals, announced that the U.S. Food and Drug Administration (FDA) had granted approval of MIUDELLA (copper intrauterine system) for the prevention of pregnancy in females of reproductive potential for up to three years. MIUDELLA is a next-generation, hormone-free, low-dose copper intrauterine device or IUD, the first to be approved by the FDA in the United States in over 40 years
• In July 2023, Perrigo Company plc that the U.S. Food and Drug Administration (FDA) approved Opill, a progestin-only daily oral contraceptive, for over-the-counter (OTC) use for all ages. Opill is the first ever birth control pill available over the counter in the U.S.

👉 Discuss Implications for Your Industry Request Sample Research Report PDF @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=344

Key Market Drivers

• Delayed Parenthood Trends: A rising global tendency among the 25–34 age group to prioritize career goals, leading to a surge in long-term hormonal contraceptive use.
• Government Support: Significant budget allocations (e.g., U.S. Title X growth and India’s National Family Planning Program) are subsidizing LARCs and oral pills.
• Rise of Telemedicine: Online consultations for birth control management have risen by 150% since 2022, particularly among Gen Z users seeking asynchronous care.
• Non-Hormonal Innovation: Increasing demand for “clean” or “organic” options due to concerns over side effects (mood swings, blood clots), making non-hormonal barriers a high-growth niche.

Market Segmentation

➤ By Product Type

• Drugs: (Oral Pills, Injectables, Topical patches)
• Devices: (Condoms, IUDs, Subdermal Implants, Vaginal Rings, Diaphragms)

➤ By Distribution Channel

• Retail Pharmacies: (Dominant at ~37%; leader in accessibility and consumer trust)
• Hospital Pharmacies & Clinics: (Critical for LARC insertions and surgical procedures)
• Online Channels: (Fastest-growing segment, expanding at a 7.11% CAGR)

➤ By Region

• North America: (Largest market share at ~40%; high awareness and favorable reimbursement)
• Asia-Pacific: (Fastest-growing region; CAGR of ~8.5% driven by China and India)
• Europe: (Strong focus on cost-effective, sustainable, and eco-friendly packaging)

Conclusion

By 2035, the contraceptives market will be defined by Personalization and Autonomy. The shift from “one-size-fits-all” hormonal pills to AI-tailored and non-hormonal options will likely reduce user discontinuation rates significantly. Furthermore, as male hormonal contraceptives move through late-stage clinical trials in 2026, the market is poised for a structural rebalancing where contraceptive responsibility is more evenly distributed across genders.

👉 To buy this comprehensive market research report, click here to inquire @ https://www.transparencymarketresearch.com/checkout.php?rep_id=344&ltype=S

FAQs

• How big was the global contraceptives market in 2024?

It was valued at US$ 31.1 Bn in 2024

• What is the projected size of the contraceptives market by 2035?

It is projected to cross US$ 52.2 Bn by the end of 2035

• What are the factors driving the contraceptives market?

Growing awareness of family planning and reproductive health and government support and favorable policies

• What is the contraceptives industry expected to grow during the forecast period?

It is anticipated to grow at a CAGR of 5.3% from 2025 to 2035

Which region is expected to dominate the contraceptives market during the forecast period?

North America is expected to account for the largest share from 2025 to 2035

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com